Medpace (MEDP) director vests 49 RSUs; holdings 10,246 shares

Cornelius P. McCarthy III, a director of Medpace Holdings, Inc. (MEDP), reported a vesting-related transaction dated 09/30/2025.

Rhea-AI Filing Summary

Cornelius P. McCarthy III, a director of Medpace Holdings, Inc. (MEDP), reported a vesting-related transaction dated 09/30/2025. 49 restricted stock units converted into 49 shares of common stock at $0 consideration, and the report shows the reporting person beneficially owns 10,246 shares following the transaction. The restricted stock units stem from a grant of 198 RSUs on 11/29/2024 that vest in four approximately equal installments on 3/31/2025, 6/30/2025, 9/30/2025, and 12/31/2025.

This Form 4 indicates a routine vesting event rather than an open-market purchase or sale; the transaction code is reported as "M" for vesting. The filing was signed by an attorney-in-fact on behalf of the reporting person.

Insider Trade Summary

49 shares exercised/converted

Exercise 2 txns

Insider McCarthy Cornelius P. III

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	49	$0.00	$0.00
Exercise	Common Stock	49	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 49 contracts (Direct); Common Stock — 10,246 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
2. F2. On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Cornelius P. McCarthy III report on Form 4 for MEDP?

The report discloses the vesting conversion of 49 restricted stock units into 49 shares of Medpace common stock on 09/30/2025.

How many MEDP shares does the reporting person hold after the transaction?

The Form 4 shows the reporting person beneficially owns 10,246 shares following the reported transaction.

What was the original RSU grant that produced these vested units?

The reporting person was granted 198 RSUs on 11/29/2024, vesting in four approximately equal installments on 3/31/2025, 6/30/2025, 9/30/2025, and 12/31/2025.

What does transaction code "M" mean on this Form 4?

On this filing, code M indicates the transaction was a conversion of restricted stock units upon vesting (vesting-related issuance).

Was any cash paid for the vested shares?

No cash was paid; the Form 4 shows the price for the vested shares as $0, reflecting conversion of RSUs to common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

McCarthy Cornelius P. III

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OH 45227

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		M		49	A	(1)	10,246	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/30/2025		M			49	(2)	(2)	Common Stock	49	$0	49	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

2. On November 29, 2024, the Reporting Person was granted 198 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Cornelius P. McCarthy III	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.